bluebird bio, Inc.
BLUE · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $47,585 | $534,673 | $666,098 | $1,250,776 |
| - Cash | $78,744 | $62,305 | $70,651 | $144,067 |
| + Debt | $188,144 | $358,238 | $365,023 | $390,420 |
| Enterprise Value | $156,985 | $830,606 | $960,470 | $1,497,129 |
| Revenue | $38,712 | $38,521 | $10,612 | $16,101 |
| % Growth | 0.5% | 263% | -34.1% | – |
| Gross Profit | $26,475 | $15,732 | -$1,169 | -$12,845 |
| % Margin | 68.4% | 40.8% | -11% | -79.8% |
| EBITDA | -$7,683 | -$8,996 | -$39,744 | -$59,393 |
| % Margin | -19.8% | -23.4% | -374.5% | -368.9% |
| Net Income | -$29,069 | -$28,712 | -$60,808 | -$81,393 |
| % Margin | -75.1% | -74.5% | -573% | -505.5% |
| EPS Diluted | -2.98 | -0.45 | -0.95 | -1.27 |
| % Growth | -562.2% | 52.6% | 25.2% | – |
| Operating Cash Flow | -$43,442 | -$50,164 | -$68,928 | -$66,252 |
| Capital Expenditures | -$859 | -$485 | -$280 | -$59 |
| Free Cash Flow | -$44,301 | -$50,649 | -$69,208 | -$66,311 |